Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenfu Injection Acupoint Injection for Diabetic Peripheral Neuropathy
ChiCTR-IPR-17011008Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Mar 2017
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of shenfu injection in diabetic polyneuropathy (DPN) (3 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Neurophysiological detection and Toronto Clinical Scoring System (TCSS). Started Mar 2017; status: recruiting.
02
Drugs
shenfu injection
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on ChiCTR-IPR-17011008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011008.